Department of Urology, Rush University Medical Center, Chicago, Illinois, USA.
Department of Urology, University of Verona, Verona, Italy.
Int J Med Robot. 2024 Feb;20(1):e2622. doi: 10.1002/rcs.2622.
The treatment paradigm for ureteropelvic junction obstruction (UPJO) has shifted towards minimally invasive pyeloplasty. A comparison Single Port (SP) and Multi Port (MP) robot-assisted pyeloplasty (RAP) was performed.
Data from consecutive patients undergoing SP RAP or MP RAP between January 2021 and September 2023 were collected and analysed. Co-primary outcomes were length of stay (LOS), Defense and Veterans Pain Rating Scale (DVPRS), and narcotic dose. The choice of the robotic system depended on the surgeon's preference and availability of a specific robotic platform.
A total of 10 SP RAPs and 12 MP RAPs were identified. SP RAP patients were significantly younger [23 years (20-34)] than MP RAP [42 years (35.5-47.5), p < 0.01]. No difference in terms of OT (p = 0.6), LOS (p = 0.1), DVPRS (p = 0.2) and narcotic dose (p = 0.1) between the two groups was observed.
SP RAP can be implemented without compromising surgical outcomes and potentially offering some clinical advantages.
肾盂输尿管连接部梗阻 (UPJO) 的治疗模式已经转向微创肾盂成形术。比较了单端口 (SP) 和多端口 (MP) 机器人辅助肾盂成形术 (RAP)。
收集并分析了 2021 年 1 月至 2023 年 9 月期间连续接受 SP RAP 或 MP RAP 的患者的数据。主要转归指标为住院时间 (LOS)、防御和退伍军人疼痛评分量表 (DVPRS) 和阿片类药物剂量。机器人系统的选择取决于外科医生的偏好和特定机器人平台的可用性。
共确定了 10 例 SP RAP 和 12 例 MP RAP。SP RAP 患者明显比 MP RAP 患者年轻 [23 岁 (20-34)] [42 岁 (35.5-47.5)，p < 0.01)]。两组之间在手术时间 (OT) (p = 0.6)、住院时间 (LOS) (p = 0.1)、DVPRS (p = 0.2) 和阿片类药物剂量 (p = 0.1) 方面无差异。
SP RAP 可以在不影响手术结果的情况下实施，并可能具有一些临床优势。
